CellPort at ASGCT 2026

Advancing cell and gene therapies depends on how work is carried forward over time.

‍

From May 11–15, CellPort will be attending ASGCT in Boston.

‍

The meeting focuses on gene editing, delivery technologies, vector development, and cell therapy manufacturing across different stages of development.

‍

As that work progresses, the surrounding context becomes more important to understand. Not just individual results, but how processes were performed, how materials were handled, and how work is carried forward across teams.

‍

CellPort captures protocols, materials, and process data as work is performed, helping maintain a continuous, traceable record that supports consistency and reproducibility over time.

‍

If you’ll be in attendance, please reach out and we can coordinate a time to connect.